$9.88-0.17 (-1.69%)
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.
InfuSystem Holdings, Inc. in the Healthcare sector is trading at $9.88 with a market capitalization of $190M. Wall Street consensus targets $14.88 (4 analysts), implying a +50.6% move over the next 12 months. The stock is currently 11% below its 52-week high of $11.04, remaining 5.9% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $33.68Mβ | $36.23Mβ | $36.49Mβ | $36.00Mβ | $34.72M |
| Gross Profit | $19.68Mβ | $20.43Mβ | $20.82Mβ | $19.87Mβ | $19.17M |
| Operating Income | $1.59Mβ | $3.71Mβ | $3.81Mβ | $3.78Mβ | $618,000 |
| Net Income | $1.02Mβ | $2.04Mβ | $2.26Mβ | $2.60Mβ | -$267,000 |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic a...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
InfuSystems Holdings (INFU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The consensus price target hints at a 62.6% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
InfuSystems Holdings (INFU) is well positioned to outperform the market, as it exhibits above-average growth in financials.